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Aiolos Regulates B Cell Activation
and Maturation to Effector State
of cytokines provided by the specialized microenviron-
ment. Thus, combinatorial signaling through antigen and
other surface receptors orchestrates B cell maturation
Jin-Hong Wang,* Nicole Avitahl,*
Annaiah Cariappa,² Christof Friedrich,*
Toru Ikeda,* Anja Renold,*
and generates the appropriate effector function tailoredKonstantinos Andrikopoulos,* Luobin Liang,*
to the stimulating antigen. Such signaling cascades,Shiv Pillai,² Bruce A. Morgan*,
which operate in both lymphocyte precursors and ma-and Katia Georgopoulos³
ture lymphocytes, may ultimately target transcription*Cutaneous Biology Research Center
factors that, in turn, mediate the changes in gene ex-²Cancer Center
pression required for differentiation.Massachusetts General Hospital
A number of transcription regulators that play a pivotalHarvard Medical School
role in lymphocyte differentiation have been describedCharlestown, Massachusetts 02129
(reviewed in Georgopoulos, 1998). Of these genes, Ikaros
encodes a family of transcription factors that are essen-
tial both for commitment to the B and fetal T cell lineagesSummary
as well as in preventing proliferation of thymocytes
(Georgopoulos et al., 1994; Winandy et al., 1995; Wang etAiolos encodes a zinc finger DNA-binding protein that
al., 1996). Reduction of Ikaros activity causes illegitimateis highly expressed in mature B cells and is homolo-
TCR-mediated proliferative expansion of immature thy-gous to Ikaros. In the periphery of mice homozygous
mocytes and, in mature T cells, facilitates TCR-mediatedfor an Aiolos-null mutation, B cells exhibit an activated
entry into cell cycle (Winandy et al., 1995; Avitahl etcell surface phenotype and undergo augmented anti-
al., submitted). Hemo-lymphoid defects caused by agen receptor (BCR)-mediated in vitro proliferative re-
dominant-negative mutation in Ikaros are more severesponses, even at limiting amounts of stimulant. In vivo,
than those caused by a null mutation (reviewed in Georg-T cell±dependent B cell responses, including the for-
opoulos et al., 1997). These phenotypes, in combinationmation of germinal centers and elevated serum IgG
with the ability of the Ikaros proteins to dimerize, suggestand IgE, are detected in Aiolos-deficient mice in the
that Ikaros works in concert with other factors (Morganabsence of immunization. Auto-antibodies and devel-
et al., 1997; Hahm et al., 1998; Kelley et al., 1998) toopment of B cell lymphomas are frequently seen among
regulate commitment to the lymphoid lineages, as wellaging Aiolos mutants. In sharp contrast to conven-
as to control proliferation of immature and mature lym-tional B cells, B cells of the peritoneum, of the marginal
phocytes. Aiolos was identified as a gene encoding azone, and the recirculating bone marrow population
protein that interacts with Ikaros. It is highly homologousare greatly reduced.
to the largest of the Ikaros protein isoforms, with strong
similarities in the DNA-binding, activation, and dimeriza-
Introduction tion domains (Morgan et al., 1997). Aiolos forms hetero-
dimers with the Ikaros proteins in T and B lymphocytes;
Successful progression through the B cell differentiation however, its expression differs from that of Ikaros.
pathway and transition of a mature lymphocyte to an Whereas Ikaros message is detected as early as the
effector state are events controlled by select changes pluripotent hemopoietic stem cell and is also expressed
in gene expression. Among the earliest events in B cell in myeloid and erythroid precursors, Aiolos message is
differentiation is the expression of the immunoglobulin not present in these primitive hemopoietic populations.
(Ig) heavy chain gene sterile transcripts that mark the Aiolos is first detected at low levels in pro-B and double
accessibility of these loci for somatic recombination (Li negative (CD4282) thymocyte precursors and is greatly
et al., 1993). Recombination at these genetic loci as well upregulated as these progress to the pre-B and double
as temporal activation of the surrogate light chain genes positive (CD4181) stages of differentiation, respectively.
(Vpre-B and l5) leads to expression of the pre-B cell recep- Aiolos expression peaks in mature peripheral B cells
tor required for proliferative expansion and differentia- and is not expressed at significant levels in splenic T
tion of late pro-B to pre-B cell precursors (reviewed in cells (Figure 1D). In contrast, Ikaros is expressed in both
Karasuyama et al., 1996). The presence of the signaling mature T and B cells, but its expression peaks in imma-
components Iga/Igb in the pre-BCR complex is also a ture thymocytes (Morgan et al., 1997; T. I., unpublished
prerequisite for B cell differentiation (Gong and Nussen- data).
zweig, 1996; Torres et al., 1996). On mature peripheral To determine the role of Aiolos in lymphocyte devel-
B cells, engagement of antigen receptors causes their opment and function, we have generated mice with a
activation, elimination, or transition to a state of anergy, null mutation in Aiolos. Consistent with its lymphoid-
depending on whether a costimulatory or inhibitory re- restricted pattern of expression, Aiolos is not required
ceptor is involved (Parry et al., 1994; Klinman, 1996; during the early specification of the B and T lymphoid
Rathmell et al., 1996). Upon activation, mature B cells lineages from the hemopoietic stem cell. However, Ai-
progress to an effector state that depends on the nature olos plays an essential role during B cell maturation.
Aiolos sets thresholds of antigen receptor signaling that
control B cell activation, maturation to a germinal center³ To whom correspondence should be addressed (e-mail: Katia_
Georgopoulos@CBRC.MGH.Harvard.Edu). lymphocyte, and isotype switching. The physiological
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Figure 1. Generation of a Null Mutation in the
Aiolos Gene
(A) Recombination strategy to replace a 0.35
kB genomic fragment encompassing the 59
coding region of exon 7 with the pgk-neo gene.
(B) Southern (EcoRV digest) and PCR analysis
of tail genomic DNA of wild-type, heterozy-
gous, and homozygous mice for the Aiolos
deletion. A DNA probe (pA) derived from a
region outside the recombination locus was
used to confirm proper homologous recombi-
nation.
(C) Northern analysis of total RNA from bone
marrow (BM), spleen (Sp), and thymus (Th)
with probes from Aiolos exons 1±6, exon 7,
Ikaros, and GAPDH cDNAs.
(D) Immunohistochemical analysis of the ex-
pression of Aiolos and Ikaros proteins in
splenic sections from 4-week-old wild-type1/1
and AioD72/2 mice.
effects of lack of Aiolos from the B cell lineage are Increase in Pre-B and Decrease in Recirculating
B Cells in the Bone Marrowan increase in B cell precursors, breakdown in B cell
tolerance, and the development of B cell lymphomas. of Aiolos-Deficient Mice
In the absence of Aiolos, a significant increase (50%) inIn contrast to the expansion of conventional B cell pre-
cursors, nonconventional peritoneal B-1a B cells, mar- the number of pre-B cells was consistently detected in
the bone marrow (Figures 2A, CD45R1/CD432, and 2C,ginal zone B cells, and recirculating bone marrow B cells
are severely depleted. This suggests that Aiolos plays population D). However, no difference in the number of
cycling cells was detected in the bone marrow CD45R1distinct roles in signaling cascades that control differen-
tiation or proliferative expansion of nonconventional ver- populations between wild-type and AioD72/2 animals
(Figure 2D). Further subfractionation of pro-B cells usingsus conventional B cells.
the BP1 and CD24 markers into A, B, C, and C9 popula-
tions revealed small differences between AioD72/2 andResults
wild-type populations (Figure 2B). A small decrease in
populations A and C9 and an increase in populationGeneration of an Aiolos-Null Genomic Locus
A 0.35 kb BamHI genomic fragment containing the 59 B were noted, suggesting the accelerated progression
from fraction A to B and from fraction C9 to D.splice acceptor site of Aiolos exon 7 was replaced by
homologous recombination with pgk-neomycin (Figure In contrast to the 50% increase in AioD72/2 pre-B
cells, the long-lived recirculating CD45R11/IgM1 bone1A). This deletion (D7) was designed to disable utilization
of exon 7 by the Aiolos transcript. Two embryonic stem marrow B cells were reduced to 50% of wild-type levels
(Figure 2C, population F). A small decrease (17%) in thecell lines with homologous recombination events were
used to generate mice with germline transmission for mature naive B cell population was also noted (Figure
2C, population E). A decrease in the recirculating popu-the D7 deletion (Figure 1B). Homozygous AioD7 mutant
mice were born with the expected Mendelian frequency lation (CD45R1/IgM1/IgD1) was consistently observed
in the blood, but levels of naive B cells (CD45R1/IgM11)and were indistinguishable from wild-type littermates.
Lymphoid populations produced in the AioD72/2 mice were within normal range, indicating that they were be-
ing exported to the periphery (data not shown).do not express any form of Aiolos mRNA (Figure 1C).
In Northern blot analysis, probes made from Aiolos ex- In immature B cells, signaling through the pre-B cell
receptor leads to their proliferative expansion and differ-ons 1±6 and exon 7 failed to detect any Aiolos transcript
in RNA prepared from AioD72/2 mice, but Ikaros mRNA entiation but also causes shutdown of the unrearranged
immunoglobulin heavy chain locus by allelic exclusionwas readily seen (Figure 1C). In addition, the B cell areas
of peripheral lymphoid follicles in wild-type mice stained (Papavasiliou et al., 1995). Mutually exclusive expres-
sion of IgMa and IgMb in both wild-type and Aiolos-brightly with an Aiolos-specific polyclonal antibody
(raised to epitopes outside the deleted region), whereas deficient B cells generated on a mixed genetic back-
ground (SV129xC57) indicated that allelic exclusion waslymphoid follicles from the AioD72/2 mice did not (Figure
1D, a-Aiolos). In contrast, B cell areas stained positively unaffected (data not shown).
with an antibody specific for the Ikaros protein in both
wild-type and AioD72/2 lymphoid follicles (Figure 1D, Aiolos-Deficient Peripheral B Cells Display
an Activated Cell Surface Phenotypea-Ikaros). Moreover, Ikaros protein was detected in the
T cell areas of the follicles, whereas Aiolos was not. In No significant difference in the relative or absolute num-
ber of splenic B cells was observed between Aiolos-conclusion, replacement of the 59 end of Aiolos exon 7
with the pgk-neo gene generated an Aiolos-null allele. null and wild-type littermates analyzed between 1 to 2
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Figure 3. Aiolos-Deficient Spleens Are Characterized by B Cells
with an Activated Cell-Surface Phenotype and Numerous Germinal
Centers; Peritoneal B-1a and Marginal Zone B Cells Are Reduced
(A) FCM analysis of splenic and peritoneal B cells from 4- to 8-week-
old wild-type and AioD72/2 littermates revealed an increase in cells
with an activated (CD45R1/IgM2/class II11) phenotype and a de-
crease in naive B cells (CD45R1/IgM11). Nonconventional B-1a B
cells (CD45Rlo/CD51) but not conventional B cells (CD45R11/CD52)
were decreased in the peritoneum. Y axis, PE; x axis, FITC.
(B) Sections obtained from the spleens of 6-week-old wild-type
and AioD72/2 revealed lymphoid follicles that lacked a well-defined
marginal zone (IgM11/dark brown, indicated by MZ), whereas large
and well developed germinal centers (PNA11/blue, indicated by GC)
were frequently discerned. In sharp contrast, lymphoid follicles in
wild-type sections exhibited a well defined marginal zone and an
insignificant number of small germinal centers. Arrowheads point
to germinal centers and the marginal zone.
Figure 2. Lack of Aiolos Causes an Increase in Bone Marrow Pre-
B and a Decrease in Recirculating B Cells
(A) Three-color FCM analysis (CD45R/CD43/IgM) of bone marrow population (data not shown). Even at the early time
from 1/1 and AioD72/2 mice. Numbers represent percentage of points of analysis (1±2 months after birth), the cell sur-
CD45R1CD432/CD45R1CD431 fractions/10,000 viable bone mar- face phenotype of Aiolos-deficient splenic B cells was
row cells. Representative results are shown.
different from that of wild-type littermates. Among the(B) Four-color FCM analysis of bone marrow cells. The percentage
Aiolos-deficient splenocytes, the percentage of newlyof each fraction/3000 CD45R1CD431 cells is shown (corresponding
exported naive B cells (CD45R1/IgM111 and IgM111/percentage of total bone marrow for 1/1 mice: A [0.9], B [1.4], C
[0.8], and C9 [0.2], and for Aio D7 2/2 mice: A [0.7], B [1.7], C [0.9], IgD2) was notably decreased, whereas the number of
and C9 [0.1]). germinal center B cells (CD45R11/IgM2) was increased
(C) Three-color FCM (CD45R/CD43/IgM) analysis. Numbers repre- (Figure 3A). The number of CD45R1/IgM1 cells that con-
sent percentage of each fraction/10,000 CD45R1CD432 cells (corre-
stitute the majority of splenic B cells was not signifi-sponding percentage of total bone marrow for 1/1 mice: D [12.1],
cantly different from wild-type. There was, however, aE [6.0], and F [6.7], and for 2/2 mice: D [14.0], E [3.6], and F [2.7]).
dramatic increase in the number of mutant splenic B(D) Cell cycle analysis of CD45R2, CD45R1, and CD45R11 subpopu-
lations by PI staining for DNA content. cells expressing high levels of class II-MHC compared
to the small percentage in the wild-type. The number of
cells expressing the activation marker CD23 was alsomonths after birth. At later time points of analysis (be-
increased among the mutant population relative to wild-tween 3±6 months of age), an increase in the size of the
spleen was noted that reflected expansion in the B cell type peripheral B cells (data not shown). On the other
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hand, expression of CD22 and FcgRIIB1 receptors,
which play negative roles in BCR signaling, was compa-
rable between mutant and wild-type B cells (Figure 3A).
In addition, Northern and Western blot analysis of
splenic RNA and protein revealed that SHP-1 phospha-
tase and Lyn, downstream effectors of the FcgRIIB1,
CD22, and BCR signaling pathways, were expressed
in Aiolos-deficient splenocytes at levels comparable to
wild-type (Figure 4C, SHP; data not shown).
The increase in the number of CD45R11/IgM1/2 and
class II11 expressing B cells indicates that a significant
proportion of Aiolos-deficient splenic B cells are in an
activated state. Consistent with this, immunohistochem-
ical analysis of splenic sections from 1- to 2-month-old
unimmunized Aiolos-deficient mice revealed numerous
germinal centers that were not detected in the wild-type
(Figure 3B), suggesting that mutant B cell populations
are actively engaged in a T cell±dependent antigen-
specific maturation process, perhaps by antigens that
are unable to elicit an immune reaction in wild-type B
cells.
Lack of Marginal Zone and Peritoneal B Cells
in Aiolos-Deficient Mice
While germinal centers were increased in Aiolos-null
mice, the marginal zone, which separates the white from
the red pulp and contains B cells that stain brightly with
IgM, was either absent or greatly reduced (Figure 3B).
Consistent with the immunohistochemical data, flow cy- Figure 4. Elevated IgE and IgG and Autoantibodies in the Sera of
Aiolos-Null Micetometric analysis of splenic lymphocytes showed a re-
(A) Serum levels of IgG2a, IgG1, and IgE were elevated and IgMduction in the CD45R1/IgM111/IgD2 B cells, (Figure 3A).
levels were reduced in 6- to 8-week-old Aiolos-null animals tested.Marginal zone B cells (CD45R1/IgM111/IgD2) and the
Squares represent wild-type whereas diamonds represent mutantphenotypically similar peritoneal B-1a B cells, both of
values. The average levels of Ig in a group of nine wild-type and
which recognize carbohydrate antigens, are proposed nine mutant mice is shown. Note that one of the mutant mice had
to derive from a progenitor that is distinct from that of much higher levels of all Igs compared to the rest and it was not
conventional B cells (Kraal, 1992; Hardy et al., 1994). included in calculations to determine average values; however, it is
shown to reveal the range of Ig serum levels that can result in theSignificantly, peritoneal B-1a cells were also severely
absence of Aiolos. An increase in IgE surface expression (B) andreduced in Aiolos-deficient mice (Figure 3A), suggesting
IgE transcripts (C) was also seen among AioD72/2 splenocytes. (C)that normal differentiation of these two nonconventional
Levels of transcripts of the negative signaling molecule SHP-1 in
B cell lineages requires Aiolos. the bone marrow (BM) and spleen (Sp) remain normal.
(D) The majority of sera (9/17) from Aiolos-mutant but not from
wild-type controls exhibited strong reactivity against nuclear auto-Elevated Levels of Serum Immunoglobulins
antigens on kidney sections from wild-type mice.
and Production of Auto-Antibodies (E) OVA-TNP (100 mg) was used as a foreign antigen to immunize
in Aiolos-Deficient Mice and boost four wild-type and eight AioD72/2 mice. The TNP response
The activated state of splenic B cells in Aiolos-null mice was estimated by ELISA, and anti-TNP activity in the serum of immu-
nized and boosted mice are shown as units of absorbance at 405was reflected by an increase in serum immunoglobulin
nm (A405). As a self-antigen, mouse Ikaros protein (6 and 60 mgs)levels (Figure 4A). The majority of mutant animals exhib-
was used to immunize and boost a group of four wild-type and fourited an increase in serum IgG2a (by 4.5-fold), IgE (by
AioD72/2 mice that had no detectable levels of Ikaros autoantibodies
2-fold), and IgG1 (by 1.84-fold) relative to wild-type. In prior to immunization. Ten days after each injection, anti-Ikaros
contrast, a 3-fold reduction in IgM and smaller reduc- activity was estimated by ELISA. A405 units are shown for the 1:800
tions in IgG2b (1.34-fold) and IgG3 (1.25-fold) were seen. dilution of serum from wild-type and mutant animals injected with
6 mgs of protein and for the 1:1600 dilution of serum from animalsThe increased levels of certain IgG isotypes and IgE,
injected with 60 mgs of protein.usually detected in the sera of animals after a secondary
immune response, suggest that B cell populations in
the peripheral lymphatic centers of Aiolos-mutant mice
switch to the g and e loci and differentiate into IgG- and transcripts in 50% of the mutant animals analyzed,
whereas other constant region transcripts were not de-IgE-producing plasma B cells. Consistent with this, in
some of the Aiolos-mutant mice analyzed, a significant tected at significant amounts (Figure 4C; data not
shown), and IgE transcripts were not detected in wild-proportion of the peripheral B cells were positive for IgE
but not for other surface receptors (Figure 4B; data not type animals (Figure 4C).
These results indicate that Aiolos-null animals mountshown). Furthermore, mRNA analysis of the spleens of
unimmunized animals revealed significant levels of IgE immune responses in the absence of a foreign antigenic
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challenge. Accordingly, autoantibodies reactive with seen when whole anti-m antibodies were used. There-
fore, in the absence of Aiolos, B cells are hyperrespon-kidney sections of wild-type mice were detected in the
majority (9/17) of sera collected from 5±16 weeks (Figure sive to BCR signaling due to enhanced positive as well
as diminished negative signaling. In addition, anti-IgM4D). Sera from age-matched controls did not have any
significant levels of auto-antibodies (Figure 4D). There- F(ab9)2 was able to activate Aiolos-deficient B cells at
concentrations that did not activate wild-type cells (Fig-fore, a lack of Aiolos in the adult immune system can
cause a breakdown in B-cell tolerance. ure 5C). Therefore, the absence of Aiolos lowers the
activation threshold in B cells so that fewer BCR engage-
ment events are required to activate a quiescent cell.T Cell±Dependent Humoral Immune Responses
The presence of germinal centers in the spleens ofin Aiolos-Deficient Mice
unimmunized Aiolos-deficient mice suggested that theIn Aiolos-deficient mice there is a decrease in the long-
lack of Aiolos also lowered thresholds for signaling path-lived recirculating and in the marginal zone B cells,
ways that direct T cell±dependent B cell immune re-which may serve as a reservoir of memory B cells (Dunn-
sponses and involving CD40/CD40L interactions on theWalters et al., 1995). A potential result of this could be
respective lymphocytes (Han et al., 1995). However, Ai-that secondary immune responses may be compro-
olos-deficient B cells showed only a 1.5- to 1.7-fold-mised.
higher proliferation relative to wild-type upon activationTo test this, wild-type and Aiolos-null mice were im-
with anti-CD40 (Figure 5D). A synergy of lower signalingmunized and then boosted with 100 mg of the T-depen-
thresholds in both the BCR and CD40 pathways maydent antigen TNP-OVA. Wild-type and Aiolos-null mice
account for the facilitated differentiation and prolifera-gave similar anti-TNP antibody titers over a period of 3
tion of Aiolos-deficient B cells into germinal centers.months (Figure 4E; data not shown); therefore, there was
no difference in the T cell±dependent immune responses
generated by Aiolos-null and wild-type animals. Given Proliferative Responses and Cytokine Production
in Aiolos-Null T Cellsthat auto-antibodies were frequently detected in the
sera of Aiolos-null mice, we also examined their ability In contrast to B cells, T cell development in Aiolos-null
animals is relatively unaffected. Thymocyte populationsto mount and maintain an immune response against
self proteins. Murine Ikaros protein was injected at two from Aiolos-deficient mice were indistinguishable from
those of wild-type animals in both cell surface pheno-concentrations into wild-type and Aiolos-null mice, and
the immune response was tested 2 weeks after the first type and number, and mature T cells were present in
normal numbers in the spleen (Figures 6A and 6B). How-boost. Significantly, the average antibody response to
the murine Ikaros protein was greater by 2-fold in the ever, a 2- to 3-fold increase in TCR-mediated prolifera-
tive responses of Aiolos-deficient relative to wild-typeAiolos mutants injected with the higher concentration
relative to wild-type littermates (Figure 4E). thymocytes was detected in vitro (Figure 6C). Peripheral
Aiolos-deficient T cells also exhibited a 1.3- to 4-fold
increase in TCR-mediated proliferation relative to wild-Augmented In Vitro Proliferative Responses
type T cells over a range of cell concentrations (Fig-in Aiolos-Null B Cells
ure 6D).The proliferative response of Aiolos-deficient peripheral
Given the increase in serum levels of certain immuno-B cells to immunoglobulin receptor (BCR) engagement
globulin isotypes in Aiolos-deficient mice, we examinedwas tested in vitro. Treatment of mature B cells with
cytokine production by activated T cells. Shortly afteran intact anti-mouse m antibody causes only moderate
TCR and CD28 coreceptor engagement, a greater num-proliferation due to coligation of the BCR and FcgRIIB1,
ber of activated Aiolos-deficient CD8 and CD4 T cellsa low-affinity receptor for IgG. Signaling via the FcgRIIB1
expressed intracellular IFNg and IL-2 (Figures 6E andinterferes with Ca21 mobilization induced by BCR en-
6F). However, levels of T cells expressing intracellulargagement, thus attenuating the proliferative response
IL-4 were similar between Aiolos-deficient and wild-typeof a B cell (Hippen et al., 1997). Aiolos-deficient B cells
populations (data not shown).exhibited by far a greater proliferative response (4- to
20-fold) relative to wild-type after treatment with anti-m,
with the response correlating inversely with cell concen- Development of Lymphomas in Aiolos-Null Mice
The hyperproliferative phenotype of B cells in Aiolos-tration (Figure 5A). These data suggest that lack of Aiolos
either interferes with negative signaling through the deficient mice correlated with the development of B cell
lymphomas in aging animals. Within a group of twentyFcgRIIB1 receptor or augments the positive response
to BCR cross-linking to override negative signaling. Aiolos-null mice between 8 to 10 months of age, six
animals developed lymphoproliferations in the periph-To distinguish between these two possibilities, activa-
tion assays were performed in which negative signaling eral lymphatic organs (Figure 7A). Of the five mice ana-
lyzed, four had developed B cell lymphomas, whereasvia the FcgRIIB1 receptor was eliminated by using
F(ab9)2 fragments instead of whole anti-m antibodies as one had developed a T cell lymphoproliferation (data
not shown). Cell surface phenotypes of clonal B cella stimulant. In the absence of negative signaling, Aiolos-
deficient B cells proliferated better than wild-type (Fig- populations in these animals ranged from CD45R1/2 and
IgMlo-int (Figure 7B) and were successfully propagated inure 5B), indicating an increase in positive signaling.
However, this increase was only 2- to 3-fold over the vitro, indicating a transformed phenotype. In addition to
the mice that developed lymphomas, sick mice with norange of cell concentrations tested (Figure 5B) and,
hence, cannot account for the 4- to 20-fold difference obvious signs of lymphoproliferative disease were also
Immunity
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Figure 5. B Cell Proliferative Responses in the Absence of Aiolos
Splenocytes and purified splenic B cells (5±40 3 104) from two wild-type and three Aiolos-deficient mice were incubated with anti-IgM (A),
anti-IgM(Fab9)2 (B), anti-CD40 1 IL-4 (D) or media alone (data not shown) for 48 hr. (C) Splenocytes (105) from three wild-type and five Aiolos-
deficient mice were activated for 48 hr with a range (0±10 mg) of anti-IgM(Fab9)2 concentrations. Activation assays were performed in triplicate
and the average of numbers that exhibited less than 15% variability are shown as squares (wild-type values) or diamonds (mutant values).
The average 3H-thymidine incorporation for the group of wild-type and AioD72/2 animals was calculated and shown as a horizontal line.
observed, but these died before analysis was per- of Ikaros to localize in these structures (data not shown).
Importantly, these Aiolos/Ikaros structures colocalizeformed. Further studies on aging Aiolos-deficient mice
will explore the possible incidence of autoimmune dis- with methyltransferase (Figure 8C), which associates
with the DNA replication machinery in cycling cellsease in these animals.
(Leonhardt et al., 1992). During S phase of the cell cycle,
a subset of active DNA replication foci, revealed by BrdUAiolos and Ikaros Proteins Are Part of the Same
Macromolecular Complex that Undergoes labeling, also colocalize with the Aiolos/Ikaros toroids
(Figure 8D). Thus, Aiolos and Ikaros proteins may controlDynamic Changes during the B Cell Cycle
As a first step in addressing the molecular mechanism cell cycle of B cells directly, possibly by coordinating
progression with events in DNA replication.by which Aiolos proteins function in B cell activation,
the subcellular localization of Aiolos and Ikaros was
determined during this process. In resting B cells, both Discussion
Aiolos and Ikaros proteins are present in a diffuse pat-
tern in the nucleus with a significant amount localizing Our present investigation identifies Aiolos, a lymphoid-
restricted member of the Ikaros gene family, as a regula-in discrete foci (Figure 8A). Upon B cell activation, the
discrete Aiolos and Ikaros foci are replaced by toroidal tor of B cell differentiation, proliferation, and maturation
to an effector state. In the absence of Aiolos, there is astructures (Figures 8B±8D) that form in G1 and persist
through S phase (data not shown). Both proteins colo- significant increase in the number of bone marrow pre-B
cells that is accompanied by small but significantcalize within the same structures in both resting and
activated cells (Figures 8A and 8B), consistent with the changes within the pro-B cell subpopulations, sug-
gesting accelerated progression from the pro-B to thefact that they can be coimmunoprecipitated from nu-
clear extracts of primary lymphocytes (Morgan et al., pre-B cell stage. Naive B cells of the bone marrow and
the blood are within normal range, but recirculating B1997). The absence of Aiolos does not affect the ability
Aiolos in B Cell Activation
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Figure 7. Development of B Cell Lymphoma in the Periphery of
Aging Aiolos-Null Mice
(A) In the affected aging mutant animals, lymph nodes (arrowheads)
are enlarged by 10- to 50-fold. (B) FCM analysis of lymph node cells
from this animal revealed an expanding B cell clone with a CD45R2/
IgMint cell surface phenotype and an increase in IgE1/CD45R1 B
cells. The spleen is enlarged (arrow) due to the expansion of B cell
Figure 6. Differentiation, Proliferative Responses, and Cytokine clones whose cell surface phenotype (CD45R2/IgMlo-int) is similar to
Production in Aiolos-Deficient T Cells that of the clones found in the lymph nodes.
(A and B) The cell surface phenotype of wild-type and AioD72/2
thymic and splenic T cells was analyzed. Normal thymocyte and T
cell profiles in both relative and absolute numbers were present in
Aiolos-deficient B cells are actively engaged in T cell±Aiolos-null mice. Y axis, PE; x axis, FITC.
dependent immune responses, possibly directed against(C and D) Proliferative responses of thymocytes and splenocytes
self- and/or levels of environmental antigen that are in-(2.5±20 3 104) were estimated 48 hr after TCR activation. Four Aiolos-
deficient and three wild-type controls were used in triplicate activa- capable of eliciting a response in wild-type lympho-
tion assays and the average proliferative response for each group cytes. The presence of autoantibodies in the sera of
of mice is shown as a horizontal line. many of the Aiolos-null mice supports this hypothesis.
(E and F) Peripheral CD8 and CD4 T cells were tested for intracellular
As detailed below, Aiolos-null B cells are hyperrespon-levels of cytokines (E-INFg and F-IL-2 and data not shown) 4 hr
sive to engagement of the IgM and CD40 receptors inafter stimulation with anti-TCR and anti-CD28.
vitro, which may facilitate their differentiation into germi-
nal center B cells in vivo.
In the majority of adult Aiolos-null animals, moderatecells are reduced by 50%. In the periphery, normal num-
bers of B cells are seen at first among the young (2±8 increases in IgG2a, IgE, and IgG1, accompanied by a
decrease in IgM, are detected in the sera, and a signifi-weeks old) Aiolos-null mouse population. However, over
time (3±8 months) an increase in peripheral B cells is cant proportion of peripheral B cells express IgE as a
surface receptor and at the mRNA level. Thus, in thedetected that causes a significant increase (2- to 5-fold)
in the size of the spleen and other lymphatic organs. spleens of Aiolos-null animals there is preferential
switching to the Cg2a, Ce, and Cg1 constant regionsAmong the aging Aiolos-null mice, incidence of B cell
lymphoma in the periphery is frequently encountered, and expansion of B cells that are positive for surface IgE.
Ig switching to the Cg1 and Ce loci is, in part, directed bywith malignant B cell clones being of CD45R1/2/IgM2/int
cell surface phenotype. Even in the young Aiolos-null signaling via the IL-4 and CD40 receptors (Mandler et
al., 1993; Warren and Berton, 1995), while switching tomice (2±8 weeks old), a significant proportion of B cells
expresses high levels of activation markers and low lev- the Cg2a locus is directed by IFNg signaling (Collins
and Dunnick, 1993). Activated Aiolos-deficient T cellsels of surface IgM. This activated cell surface phenotype
correlates with a large number of germinal centers found produce increased amounts of IFNg, which may account
for an increase in the frequency of switching to the Cg2ain the spleens of young, unimmunized Aiolos mutants
not seen in wild-type littermates. This suggests that locus. However, IL-4 production from these T cells is
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FcgRIIB1 or their downstream effectors (D'Ambrosio et
al., 1995, 1996; O'Keefe et al., 1996; Sato et al., 1996;
Takai et al., 1996; Hippen et al., 1997). However, both
the CD22 receptor and its downstream effector SHP-1
are expressed at levels comparable to wild-type in Ai-
olos-null B cells. Thus, lack of expression of these nega-
tive signaling molecules cannot be the cause of the
hyperresponsiveness in Aiolos-null B cells. Coligation
of membrane Ig and FcgRIIB1 receptor occurs in vivo
when B cells encounter immune complexes that contain
immunoglobulin and exposed antigenic determinants
recognized by the BCR and serves to attenuate ongoing
antibody responses. In sharp contrast to wild-type, Ai-
olos-null B cells proliferate well after in vitro treatment
with the intact anti-IgM molecule, indicating that nega-
tive signaling events elicited upon FcgRIIB1 receptor
engagement do not have the same effect. FcgRIIB1 re-
ceptor and the tyrosine kinase Lyn (Chan et al., 1997),
which serve as negative effectors of BCR signaling, are
present at normal levels in the Aiolos-deficient B cells.
Thus, Aiolos may lie downstream of these signaling cas-
cades and serve as a nuclear effector that controls the
outcome of B cell receptor signaling. In this way, Aiolos
might act as a molecular threshold that regulates entry
into the cell cycle and can be overcome by BCR signal-
ing. The fact that Aiolos-deficient B cells do not prolifer-
ate spontaneously in the absence of receptor engage-
ment may be due to the activity of Ikaros, which is also
expressed in B cells.Figure 8. A Cell Cycle±Regulated Macromolecular Protein Complex
In spite of the production and increased proliferationContaining Aiolos Colocalizes with DNA Replication Foci
of conventional B cells (B-2), peritoneal B-1a B cells,Resting (A) and LPS-activated splenocytes (B) from a wild-type
splenic marginal zone B cells, and bone marrow recircu-mouse were fixed and stained for Aiolos (green) or Ikaros proteins
(red). Superimposition of the images reveals that the two proteins lating B cells are greatly reduced in the Aiolos-null mice.
colocalize (seen as yellow) within the same nuclear structures in both The lower levels of serum IgM present in the Aiolos
resting and activated lymphocytes. (C) The Aiolos/Ikaros toroidal mutants may be a consequence of the decrease in peri-
structures (red) that form in G1 upon B cell activation colocalize
toneal B-1a B cells. B-1a lineage cells have been shownwith methyltransferase (green). (D) Activated splenocytes pulsed
to be a source of low-affinity autoreactive IgM antibod-with BrdU show a number of DNA replication foci where Aiolos
ies (Murakami and Honjo, 1995). However, this popula-protein (red) and BrdU (green) colocalize (seen as yellow). The dis-
crete pattern of BrdU foci in these S-phase cells demarcates replica- tion is not the source of autoantibody production in
tion of heterochromatic regions that takes place during mid-to-late Aiolos-null animals since it is severely reduced and the
S phase. antibodies produced in the mutant animals are predomi-
nantly of the IgG and IgE isotypes. These studies reveal
the existence of distinct molecular requirements for the
normal and cannot account for the frequent switching differentiation and/or antigen-driven expansion of con-
to the Ce and Cg1 loci that occurs within the Aiolos- ventional versus nonconventional B cell lineages. The
deficient B cell populations. Since Aiolos does not ap- specialized role of Aiolos in the development of noncon-
pear to regulate IL-4 production in T cells, it is likely to ventional B cells is also revealed by the reduction of
participate directly in the IL-4 receptor signaling path- marginal zone B cells in mutant animals, which are
way in B cells. In the absence of Aiolos, the signaling thought to derive from a distinct progenitor from that of
threshold for this pathway may be lowered so that conventional B cells. An alternative explanation is that
switching to the Ce and Cg1 loci occurs in response to reduction of both marginal zone and recirculating B cells
suboptimal levels of the cytokine. is the result of a decrease in their lifespan caused by
While Aiolos may control IL-4 receptor signaling, it increased receptor signaling.
clearly does so for the BCR signaling pathway. Upon The first insights in understanding the molecular
BCR ligation, more of the Aiolos-deficient peripheral B mechanism by which Aiolos sets signaling thresholds
cells proliferate compared to the wild-type population. in B cells are provided by immunofluorescence studies
Moreover, conditions that are insufficient to promote that reveal that Aiolos is part of a dynamic nuclear mac-
activation and proliferation of wild-type B cells, i.e., a romolecular complex. In resting B cells, a significant
limiting number of BCR engagement events and low cell amount of Aiolos is present in discrete foci that change
density, produce good proliferative responses in the into toroidal structures upon activation (G0 to G1 transi-
Aiolos-null B cells. Lowering of the signaling threshold tion). Ikaros is also present in these nuclear structures
could be achieved by reducing expression of recep- and is unaffected by the lack of Aiolos. A recent study
of Ikaros protein in B cell lines reports its presence intors involved in negative signaling such as CD22 and
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similar cup-like structures in G1 and shows sequestra- for these and possibly other signaling pathways, bridg-
ing events that take place on the cell surface with thosetion of this protein in a heterochromatin-associated
complex (Brown et al., 1997). The Aiolos/Ikaros toroids that occur in the nucleus. Both Aiolos and Ikaros may
function as tumor supressors by controlling cell cyclethat form in early G1 are maintained through S phase
and colocalize with methyltransferase and with DNA entry, DNA replication, and stable chromosome propa-
gation, with Aiolos more tailored to couple these to BCRreplication clusters that have been shown to be active
in mid through late S phase (Nakayasu and Berezney, signaling and Ikaros playing the major role in integrating
TCR signaling. High levels of Aiolos and Ikaros proteins1989; O'Keefe et al., 1992). Several components of the
DNA replication machinery and their cell cycle regulators in mature and differentiating B and T cells, respectively,
may be required to coordinate a series of molecular(i.e., DNA polymerase, RPA70, PCNA, methyltransfer-
ase, cyclin A, and cdk2) have been shown to colocalize events like DNA recombination, switching, and somatic
hypermutation with DNA replication during their expan-with BrdU-labeled replication clusters and form a higher-
order assembly that is associated with the nuclear ma- sion phases. This dynamic complex of nuclear factors
has a unique stronghold on cell cycle regulation, possi-trix in a mega-complex (Leonhardt et al., 1992; Cardoso
et al., 1993; HozaÂ k and Cook, 1994). Such replication bly by regulating chromatin structure of replicating DNA.
It also controls select changes in gene expression re-factories may interact with DNA-binding factors like Ai-
olos and Ikaros and recruit enhancer sites to sites of quired for B and T cell differentiation (A. Nichogianno-
poulou and K. G., unpublished data). Further studies onDNA replication (Heintz, 1992). Aiolos/Ikaros complexes
forming on these DNA replication sites may be essential BCR and other receptor signaling pathways and their
effects on Aiolos and Ikaros protein activity during thefor restricting their amplification to once per cell cycle.
Deregulation of such events in DNA replication in Aiolos- cell cycle will establish the molecular basis for the wide
range of biological effects delivered by these factorsdeficient B cells or Ikaros-deficient T cells may cause
gene amplification and transformation to a neoplastic throughout development of the lymphoid system.
state (Avitahl et al., submitted).
Experimental ProceduresIn a parallel study, we have recently shown that reduc-
ing levels of Ikaros activity in mature T cells lowers their
Cloning of the Aiolos Gene, Recombination Constructs,activation threshold and causes accelerated entry into
and Targeting of ES CellsS phase (Avitahl et al., submitted). Significantly, in vivo Overlapping clones were isolated from a liver genomic library
reduction in Ikaros levels leads to a breakdown in T cell (SV129) that covers a region of 100 kB containing 7 translated exons
tolerance, as manifested by the appearance of ªforbid- of Aiolos (unpublished data). The recombination vector described
in Figure 1A was constructed with Aiolos genomic fragments fromdenº Vb specificities, and to the rapid development of
this region, and pgk-neomycin and was transfected into J1 embry-T cell malignancies (Winandy et al., 1995; Wang et al.,
onic stem cells. Neomycin-resistant ES cell colonies were analyzed1996). Ikaros proteins are incorporated into similar mac-
by Southern blotting using DNA probes from outside the homolo-romolecular structures in activated T cells and their ab- gous recombination area (Figure 1A). Two distinct ES cell lines het-
sence correlates with chromosomal abnormalities after erozygous for this mutation were used in separate blastocyst injec-
a limited number of cell cycles in vitro, indicating that tions. The genotype of F1 and F2 mice was determined by Southern
and by PCR analysis of tail DNA using either probe A (Figure 1A) orthis family of nuclear factors are critical for the stable
primers designed from the neomycin (Neo1) and the Aiolos genepropagation of genetic material.
(Int6-F and Ex7R). Int 6F, CAGCACCCCTAAACATGTGACTG; Ex7R,In a similar fashion to Ikaros in T cells, lack of Aiolos
GGCGATGTGAGAGGAGAACTCATA; and Neo1, CCAGCCTCTGAGin B cells facilitates their entry into cell cycle, maturation CCCAGAAAGCGA.
to germinal center lymphocytes, and causes a break-
down in B cell tolerance and the development of B cell Northern Hybridizations
malignancies. In contrast to the proliferative and differ- RNA was prepared from bone marrow, spleen, and thymus of wild-
type and AioD7 2/2 mice. Probes used to probe for Northern blotsentiation effects that the Aiolos mutation brings to the
were as follows. The N-terminal Aiolos probe consisted of a 1.46B cell lineages, more minor effects are apparent in T
kB EcoRI±BamHI fragment derived from a cDNA clone of Aioloscells, which may reflect its reciprocal pattern of expres-
covering exons 1±6 and 140 bp of exon 7. The C-terminal probe
sion relative to Ikaros in these lymphocyte populations. consisted a 330 bp fragment derived from exon 7 of Aiolos. Probes
Thymocyte differentiation and the number of peripheral used to identify the Ce, Cg1, and Cg2b transcripts were derived
T cells are normal, and only a modest increase (2- to from the vectors pE, pg1BX, and SKA, respectively, as described
in Kim et al. (1996). Plasmids were a gift from A. Bottaro.4-fold) in the proliferative capacity of thymocytes and
mature T cells is seen. In sharp contrast, a decrease in
Immunohistochemistrythe levels of Ikaros in immature thymocytes causes a
Tissues harvested from euthanized wild-type and Aiolos-mutantdramatic increase in their TCR-mediated proliferative
mice were snap-frozen in OCT, sectioned at 5±8 mM thickness, air
capacity in vitro (50- to 100-fold) (Winandy et al., 1995). dried for 15 min, and stored at 2808C until use. Anti-Ikaros and
Nevertheless, some of the facilitated B cell maturation anti-Aiolos antibodies (0.2 mg/ml) were applied on sections and
effects detected in vivo in Aiolos-mutant mice, i.e., ger- incubated overnight at 48C. Sections were then treated with goat-
anti-rabbit secondary antibody conjugated to horseradish peroxi-minal center formation and switching to IgG2a, IgE, and
dase (HRP) (VECTOR laboratories Inc, CA). For the chromogenicIgG1, may be caused by the combined effects of the
reaction, diaminobenzidine tetrahydrochloride (DAB) was used asAiolos mutation on mature T cells and deregulation of
a substrate and sections were counterstained with Mayer's hema-B cell signaling pathways in mature B cells.
toxylin. To visualize B and T cell areas in the spleen, sections were
B cell differentiation, proliferation, and persistence first blocked with 1:100 normal goat serum 1 0.3% H2O2 1 1 mM
rely on the pre-BCR/BCR signaling cascades (Lam et levamisole for 30 min at room temperature (RT) and then incubated
with anti-mouse IgM-HRP (1:200) for 60 min at RT and developedal., 1997). Aiolos and Ikaros are critical nuclear effectors
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with DAB. Sections were then stained with biotinylated anti-mouse were pulsed with [3H] thymidine and harvested after an additional
incubation of 12 hr.CD3 or PNA (1: 200) for 60 min at RT and then developed with
streptavidin-AP (1:200) and developed with AP substrate (VECTOR
laboratories, kit IV). Light microscopy was performed at 10X magnifi- ELISAs
cation on an Olympus BMax-50 microscope. Mouse immunoglobulin isotype-specific enzyme-linked immunoad-
sorbent assays (ELISA) were carried out using isotype-specific rab-
Immunofluorescence bit anti-mouse immunoglobulins (Sigma) as the capture agent to
Whole splenocytes were prepared from wild-type mice and cultured which serum samples were added. Captured immunoglobulin iso-
for 48 hr in RPMI, 10% fetal calf serum, 50 mM b-mercaptoethanol, types were developed with goat anti-mouse IgG1IgA1IgM directly
50 mg/ml gentamicin and 25 mg/ml lipopolysaccharide (Escherichia conjugated to alkaline phosphatase (Sigma). The immunoglobulin
coli, serotype 0111:B4, Sigma). Unless specified otherwise, all ma- isotype concentrations of individual serum samples were calculated
nipulations were performed on ice using prechilled solutions. Cells by comparing the mean OD at 405 nm obtained from triplicate wells
were cytospun onto slides and then fixed and permeabilized for 20 of serial dilutions of sample sera to the standard curve. For anti-
min in cold phosphate-buffered saline (PBS)/4% paraformaldehyde/ TNP and anti-Ikaros antibody determination, serial dilutions (1:400
0.1% Tween-20. For colocalization studies, slides were incubated to 1:6400) of sample sera were added to wells coated with TNP-
with the first antibody at 48C overnight, followed by several washes BSA or murine recombinant Ikaros protein. Wells were blocked with
in cold PBS and incubation for 1 hr at room temperature with either 2% BSA, incubated with serum samples, washed extensively, and
TRITC- or FITC-conjugated donkey anti-rabbit secondary antibod- developed with goat anti-mouse IgG1IgA1IgM conjugated to alka-
ies (Jackson ImmunoResearch Laboratories, Inc.). For colocaliza- line phosphatase.
tion of Aiolos with Ikaros or methyltransferase, the second antibody
(either anti-Ikaros or anti-Aiolos, directly conjugated to Alexa 568 T-Dependent B Cell Response
[Molecular Probes]) was incubated at 48C for a minimum of 8 hr. To TNP-OVA (100 mg) and mouse recombinant Ikaros protein (6±60
visualize replication foci, cells were labeled for 10 min in 10 mM mg) in Freund's complete adjuvant (Sigma) were administered by
BrdU prior to harvest. After fixing and staining for Aiolos, the slides intraperitoneal injection. Immunized mice were boosted with antigen
were fixed and stained for BrdU as described in Leonhardt et al. in Freund's incomplete adjuvant (Sigma) every 15 days for 3 months.
(1992). Antibodies were diluted in PBS/3%BSA/1%Donkey serum/ Serum titers for antigen-specific antibodies were determined prior
1%Goat serum. Slides were mounted in Vectashield (Vector Labora- to and 10 days after each injection by ELISA.
tories, Inc.) and viewed by scanning confocal microscopy with tech-
nology from Leica. Images were processed using Adobe Photoshop
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